Key drivers for each region include: for North America, demographics with an aging population, infrastructure with well-established healthcare systems, and ecosystem maturity with a high level of awareness about respiratory therapy; for Europe, policies supporting the use of manual incentive spirometers, adoption in hospitals and clinics, and investments in healthcare research and development; for Asia Pacific, demographics with a large and growing population, infrastructure with increasing investments in healthcare, and ecosystem maturity with a growing awareness about respiratory therapy; for Latin America, policies supporting the use of respiratory therapy devices, adoption in hospitals and clinics, and investments in healthcare infrastructure; and for Middle East & Africa, demographics with a growing population, infrastructure with increasing investments in healthcare, and ecosystem maturity with a growing awareness about respiratory therapy.